Simplex Trading, LLC 180 Life Sciences Corp. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022
SELL
$0.12 - $1.31 $195 - $2,135
-1,630 Reduced 16.32%
8,359 $5,000
Q2 2022

Aug 03, 2022
BUY
$0.81 - $2.53 $3,383 - $10,567
4,177 Added 71.87%
9,989 $8,000
Q1 2022

May 02, 2022
SELL
$2.53 - $3.9 $90,427 - $139,393
-35,742 Reduced 86.01%
5,812 $15,000
Q4 2021

Feb 23, 2022
BUY
$3.27 - $6.38 $80,016 - $156,118
24,470 Added 143.23%
41,554 $162,000
Q2 2021

Aug 12, 2021
BUY
$6.7 - $11.98 $114,462 - $204,666
17,084 New
17,084 $170,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $81.1M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email